ALPHA-PE Research Fund Launched to Advance Pulmonary Embolism Care

February 5, 2026—AngioDynamics, Inc. and The PERT Consortium announced the launch of the ALPHA-PE Research Fund, an investigator-led initiative supporting independent pulmonary embolism (PE) research.

The press release stated that ALPHA-PE is designed to support independent, physician-led research addressing critical evidence gaps in PE care, which is often limited by a lack of real-world data for clinical decision-making. By enabling investigator-driven studies, the program aims to accelerate the generation of clinically relevant evidence to inform care delivery and advance understanding of PE management.

According to AngioDynamics and The PERT Consortium, awards ranging from $50,000 to $750,000 over 1 to 3 years will be distributed to both established and emerging investigators, empowering them to pursue data-driven research focused on patient outcomes, workflow optimization, or novel therapeutic approaches with the potential to improve real-world PE care, stated the press release.

The press release advised that investigators interested in applying to the ALPHA-PE Research Fund are invited to submit a brief Letter of Intent outlining study objectives, design, and budget. Selected applicants will be invited to submit full proposals for review.

Additional information about the ALPHA-PE Research Fund, including submission guidelines and timelines, are available online at angiodynamics.com/alpha-pe-research-fund/.

“We are incredibly excited about this collaboration and the opportunity it creates for the PE community,” commented Amir Darki, MD, Cochair of the National PERT Research Consortium, in the press release. “Physician-led, investigator-driven research is essential to closing critical evidence gaps in pulmonary embolism care. The ALPHA-PE Research Fund represents a meaningful investment in supporting innovation, fostering collaboration, and advancing impactful research that will directly inform real-world practice and improve patient outcomes.”